The estimated Net Worth of James A Lombard is at least $4.57 mil dollars as of 20 April 2004. Mr. Lombard owns over 200 units of Daxor stock worth over $4,570 and over the last 21 years he sold DXR stock worth over $0. In addition, he makes $0 as Independent Director at Daxor.
Sign up
Mr. Lombard DXR stock SEC Form 4 insiders trading
James has made over 1 trades of the Daxor stock since 2004, according to the Form 4 filled with the SEC. Most recently he bought 200 units of DXR stock worth $3,010 on 20 April 2004.
The largest trade he's ever made was buying 200 units of Daxor stock on 20 April 2004 worth over $3,010. On average, James trades about 29 units every 0 days since 2003. As of 20 April 2004 he still owns at least 500 units of Daxor stock.
You can see the complete history of Mr. Lombard stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
James Lombard biography
James A. Lombard is Independent Director of Daxor Corp. He holds an undergraduate degree in Business Administration (BBA) from Iona College and a Masters Degree (MBA) in Marketing, Banking, and Finance from New York University Graduate School of Business Administration. Mr. Lombard has retired as Director, Administrative Services Division of the City Council of New York and actively participates in civic and community affairs. Prior to joining the City Council, he worked in the banking industry and held various administrative positions with Citicorp and other banks.
How old is James Lombard?
James Lombard is 80, he's been the Independent Director of Daxor since 1989. There are no older and 7 younger executives at Daxor.
What's James Lombard's mailing address?
James's mailing address filed with the SEC is 109 MECO LANE, , OAK RIDGE,, TN, 37830.
Insiders trading at Daxor
Over the last 21 years, insiders at Daxor have traded over $7,541,627 worth of Daxor stock and bought 473,408 units worth $2,888,339 . The most active insiders traders include Joseph Feldschuh, Bruce Slovin y Robert J Michel. On average, Daxor executives and independent directors trade stock every 39 days with the average trade being worth of $27,740. The most recent stock trade was executed by Robert J Michel on 27 March 2024, trading 750 units of DXR stock currently worth $6,525.
What does Daxor do?
the bva-100 (blood volume analyzer) is the first instrument of its kind that can precisely measure the amount of blood a patient has in their body. blood volume measurements have been available for almost 60 years, but the test often took 4 to 8 hours to perform and was very difficult to perform accurately. due to these issues, blood volume measurements were very rarely done. physicians had been forced to rely on substitute tests that were only able to measure the thickness of the blood and can be very misleading in many surgical and medical situations. the bva-100 can measure blood volume: accurately, quickly & reliably.
What does Daxor's logo look like?
Complete history of Mr. Lombard stock trades at Daxor
Daxor executives and stock owners
Daxor executives and other stock owners filed with the SEC include:
-
Jonathan Adam Feldschuh,
Chief Scientific Officer & Director -
Michael Richard Feldschuh,
Chairman, Pres & CEO -
Diane Meegan,
IR Contact Officer -
Robert Willens,
Independent Director -
James Lombard,
Independent Director -
Joy Goudie,
Independent Director -
Edward Feuer,
Director -
Henry Cremisi,
Director -
Jonathan Feldschuh,
Chief Scientific Officer, Director -
Robert Michel,
Chief Financial Officer -
Michael Feldschuh,
Chairman of the Board, President, Chief Executive Officer -
Robert J. Michel M.B.A., CPA, CPA,
CFO, Chief Compliance Officer & Corp. Sec. -
Guido Manzo,
VP of Sales -
Kathryn A. Kornafel,
VP of Marketing & Commercial Devel. -
Robert J. Michel M.B.A., C.P.A., CPA,
CFO, Chief Compliance Officer & Corp. Sec. -
Caleb Des Rosiers,
Director -
Of Joseph Feldschuh Estate,
10% owner -
Bernhard Saxe,
Director -
Soren Thompson,
VP, Business Development -
Everis Engstrom,
Vice President -
Robert G Moussa,
Director -
Martin S Wolpoff,
Director -
Philip Nordan Hudson,
Director -
Joseph Feldschuh,
President & CEO -
Stephen Valentine,
Director -
Bruce Slovin,
Director -
Gary Joseph Fischman,
President